119 related articles for article (PubMed ID: 2845259)
21. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients.
Elrington GM; Murray NM; Spiro SG; Newsom-Davis J
J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):764-7. PubMed ID: 1659614
[TBL] [Abstract][Full Text] [Related]
22. SFEMG improvement with remission in the cancer-associated Lambert-Eaton myasthenic syndrome.
Oh SJ
Muscle Nerve; 1989 Oct; 12(10):844-8. PubMed ID: 2558313
[TBL] [Abstract][Full Text] [Related]
23. Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.
Prior C; Lang B; Wray D; Newsom-Davis J
Ann Neurol; 1985 Jun; 17(6):587-92. PubMed ID: 2992356
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
Rozsa C; Vincent A; Aranyi Z; Kovacs GG; Komoly S; Illes Z
Ideggyogy Sz; 2008 Sep; 61(9-10):325-8. PubMed ID: 18841652
[TBL] [Abstract][Full Text] [Related]
25. Lambert-Eaton myasthenic syndrome in small cell lung cancer: nursing implications.
Struthers CS
Oncol Nurs Forum; 1994 May; 21(4):677-83; quiz 684-5. PubMed ID: 8047466
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune pathogenesis of paraneoplastic neurological syndromes.
Anderson NE; Cunningham JM; Posner JB
Crit Rev Neurobiol; 1987; 3(3):245-99. PubMed ID: 3315239
[TBL] [Abstract][Full Text] [Related]
27. Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones.
Fukuoka T; Engel AG; Lang B; Newsom-Davis J; Prior C; Wray DW
Ann Neurol; 1987 Aug; 22(2):193-9. PubMed ID: 3662451
[TBL] [Abstract][Full Text] [Related]
28. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
[TBL] [Abstract][Full Text] [Related]
29. Lambert-Eaton syndrome antibodies: reaction with membranes from a small cell lung cancer xenograft.
Chester KA; Lang B; Gill J; Vincent A; Newsom-Davis J
J Neuroimmunol; 1988 May; 18(2):97-104. PubMed ID: 2833535
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
31. [A Lambert-Faton myasthenic syndrome and subacute cerebellar degeneration with a favorable clinical course after resection of small-cell lung cancer].
Shimamura M; Yamaguchi S; Kuroiwa Y
Rinsho Shinkeigaku; 2000 Oct; 40(10):1028-32. PubMed ID: 11296368
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic neurological autoimmunity and survival in small-cell lung cancer.
Maddison P; Lang B
J Neuroimmunol; 2008 Sep; 201-202():159-62. PubMed ID: 18667241
[TBL] [Abstract][Full Text] [Related]
33. Coexistence of paraneoplastic sensory neuronopathy and Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient.
Kawahara M; Furuse K; Kodama N; Ogawara M; Kubota K; Yamamoto S; Tada H; Mori T; Miyawaki Y; Hirohashi S
Jpn J Clin Oncol; 1994 Aug; 24(4):224-7. PubMed ID: 8072202
[TBL] [Abstract][Full Text] [Related]
34. [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis].
Nagayama S; Koike F; Sakai T; Antoku Y; Yukitake M; Kuroda Y
Brain Nerve; 2008 Dec; 60(12):1470-4. PubMed ID: 19110759
[TBL] [Abstract][Full Text] [Related]
35. [A case of small cell carcinoma of the lung associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome].
Seki N; Mitsui J; Hoshino M; Akishiro M; Ugawa Y; Goto J; Tsuji S
No To Shinkei; 2006 Jan; 58(1):68-73. PubMed ID: 16482925
[TBL] [Abstract][Full Text] [Related]
36. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
Kim YI
Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
[TBL] [Abstract][Full Text] [Related]
37. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland.
Wirtz PW; Nijnuis MG; Sotodeh M; Willems LN; Brahim JJ; Putter H; Wintzen AR; Verschuuren JJ;
J Neurol; 2003 Jun; 250(6):698-701. PubMed ID: 12796832
[TBL] [Abstract][Full Text] [Related]
38. Lambert-Eaton myasthenic syndrome as an autoimmune calcium-channelopathy.
Takamori M; Maruta T; Komai K
Neurosci Res; 2000 Mar; 36(3):183-91. PubMed ID: 10683522
[TBL] [Abstract][Full Text] [Related]
39. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction.
Pellkofer HL; Voltz R; Kuempfel T
Muscle Nerve; 2009 Aug; 40(2):305-8. PubMed ID: 19609921
[TBL] [Abstract][Full Text] [Related]
40. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome.
Houzen H; Hattori Y; Kanno M; Kikuchi S; Tashiro K; Motomura M; Nakao Y; Nakamura T
Ann Neurol; 1998 May; 43(5):677-80. PubMed ID: 9585366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
